These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 21057708

  • 1. The uncalibrated prothrombinase-induced clotting time test. Equally convenient but more precise than the aPTT for monitoring of unfractionated heparin.
    Korte W, Jovic R, Hollenstein M, Degiacomi P, Gautschi M, Ferrández A.
    Hamostaseologie; 2010 Nov; 30(4):212-6. PubMed ID: 21057708
    [Abstract] [Full Text] [Related]

  • 2. The PiCT® test is a reliable alternative to the activated partial thromboplastin time in unfractionated heparin therapy management: results from a multicenter study.
    Brisset AC, Ferrández A, Krause M, Rathbun S, Marlar R, Korte W.
    J Thromb Haemost; 2016 Nov; 14(11):2187-2193. PubMed ID: 27582411
    [Abstract] [Full Text] [Related]

  • 3. Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitors.
    Calatzis A, Peetz D, Haas S, Spannagl M, Rudin K, Wilmer M.
    Am J Clin Pathol; 2008 Sep; 130(3):446-54. PubMed ID: 18701419
    [Abstract] [Full Text] [Related]

  • 4. Monitoring of unfractionated heparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent (PiCT®).
    Schaden E, Jilch S, Hacker S, Schober A, Kozek-Langenecker S.
    Clin Chim Acta; 2012 Dec 24; 414():202-5. PubMed ID: 23041210
    [Abstract] [Full Text] [Related]

  • 5. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin.
    Toulon P, Boutière B, Horellou MH, Trzeciak MC, Samama MM.
    Thromb Haemost; 1998 Jul 24; 80(1):104-8. PubMed ID: 9684794
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin.
    Ip BK, Thomson AR, Moriarty HT.
    Pathology; 2001 Aug 24; 33(3):347-52. PubMed ID: 11523938
    [Abstract] [Full Text] [Related]

  • 7. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R, Jacobs C.
    Res Vet Sci; 2001 Apr 24; 70(2):101-8. PubMed ID: 11356088
    [Abstract] [Full Text] [Related]

  • 8. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb 24; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 9. Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time.
    Harenberg J, Giese C, Hagedorn A, Traeger I, Fenyvesi T.
    Semin Thromb Hemost; 2007 Jul 24; 33(5):503-7. PubMed ID: 17629847
    [Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J.
    J Mal Vasc; 1987 Jul 24; 12 Suppl B():68-70. PubMed ID: 2834495
    [Abstract] [Full Text] [Related]

  • 11. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
    Samama MM, Martinoli JL, LeFlem L, Guinet C, Plu-Bureau G, Depasse F, Perzborn E.
    Thromb Haemost; 2010 Apr 24; 103(4):815-25. PubMed ID: 20135059
    [Abstract] [Full Text] [Related]

  • 12. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.
    Vandiver JW, Vondracek TG.
    Pharmacotherapy; 2012 Jun 24; 32(6):546-58. PubMed ID: 22531940
    [Abstract] [Full Text] [Related]

  • 13. The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin.
    Mischke R, Grebe S.
    Res Vet Sci; 2000 Dec 24; 69(3):241-7. PubMed ID: 11124095
    [Abstract] [Full Text] [Related]

  • 14. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL, Howard C.
    Blood Coagul Fibrinolysis; 1993 Feb 24; 4(1):35-40. PubMed ID: 7681330
    [Abstract] [Full Text] [Related]

  • 15. Monitoring heparin therapy: relationships between the activated partial thromboplastin time and heparin assays based on ex-vivo heparin samples.
    van den Besselaar AM, Meeuwisse-Braun J, Bertina RM.
    Thromb Haemost; 1990 Feb 19; 63(1):16-23. PubMed ID: 2339357
    [Abstract] [Full Text] [Related]

  • 16. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays.
    Kitchen S, Preston FE.
    Thromb Haemost; 1996 May 19; 75(5):734-9. PubMed ID: 8725715
    [Abstract] [Full Text] [Related]

  • 17. Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): relation to FXa-activity and influence of assay modifications.
    Harder S, Parisius J, Picard-Willems B.
    Thromb Res; 2008 May 19; 123(2):396-403. PubMed ID: 18571698
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.
    Spinler SA, Wittkowsky AK, Nutescu EA, Smythe MA.
    Ann Pharmacother; 2005 May 19; 39(7-8):1275-85. PubMed ID: 15956240
    [Abstract] [Full Text] [Related]

  • 19. Monitoring heparin anticoagulation in the acute phase response.
    Uprichard J, Manning RA, Laffan MA.
    Br J Haematol; 2010 May 19; 149(4):613-9. PubMed ID: 20230412
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M.
    Arch Intern Med; 1994 Jan 10; 154(1):49-56. PubMed ID: 8267489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.